aluates Reports

$ 0.0

Automative

Global Omalizumab Injection Market Research Report 2026

Published Date: 2026-01-14

Report Code: QYRE-Auto-10Y20035

Global Omalizumab Injection Market Research Report 2025

BUY CHAPTERS

Global Omalizumab Injection Market Research Report 2026

Code: QYRE-Auto-10Y20035

Report

2026-01-14

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Reliance

Celltrion

Genentech Inc

Omalizumab Injection Market Size

The global Omalizumab Injection market was valued at US$ 5363 million in 2025 and is anticipated to reach US$ 8108 million by 2032, at a CAGR of 6.2% from 2026 to 2032.

Omalizumab Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Omalizumab Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Omalizumab injection is a targeted biological agent. It is a humanized monoclonal antibody that can precisely bind to and block immunoglobulin E (IgE), thereby preventing the release of inflammatory mediators such as histamine. It is often used to treat allergic asthma and chronic spontaneous urticaria (CSU) that do not respond well to traditional drugs (such as antihistamines), allowing patients to get rid of the troubles caused by allergic reactions and improve their quality of life.

Global production of omalizumab injection is projected to reach 7.15 million vials by 2025, with an average price of $750 per vial. Gross profit margins typically range from 65% to 80%.

The upstream supply chain of omalizumab injection mainly includes culture media and additives required for recombinant cell line construction and culture, protein purification resins and filtration consumables, disposable bioreactors and aseptic filling consumables, and packaging materials such as pre-filled glass needles or vials. The upstream supply chain has extremely high requirements for quality consistency and compliance systems. Downstream applications are the core of demand, mainly concentrated in the treatment of immune-related diseases such as severe allergic asthma and chronic spontaneous urticaria. In clinical settings, omalizumab, as an IgE-targeting biologic, is typically used for patients with insufficient response to conventional treatments, with a clear evidence-based medical foundation. It is mainly used in the respiratory, allergy, and dermatology departments of tertiary hospitals. With guideline recommendations and the accumulation of real-world data, its position in standardized long-term management is solid. In terms of payment, inclusion in medical insurance and local supplementary insurance plays a decisive role in increasing sales volume, and patient compliance and ease of administration directly affect the usage structure. Downstream customers are primarily hospitals and the medical insurance system, resulting in highly concentrated procurement, significant price negotiation, and barriers to entry.

The industry's development trend is characterized by the gradual market launch of biosimilars, driving down prices and improving accessibility. Simultaneously, optimized subcutaneous administration and an expanded patient population are contributing to structural growth. The main driving factors are the rising prevalence of allergic diseases, the promotion of standardized treatment, and expanded medical insurance coverage. Obstacles include intensified competition among biosimilars, price pressure from centralized volume-based procurement, and the substitution risk from other new mechanism biologics.

This report delivers a comprehensive overview of the global Omalizumab Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Omalizumab Injection. The Omalizumab Injection market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Omalizumab Injection market comprehensively. Regional market sizes by Type, by Application, by Specifications, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Omalizumab Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Omalizumab Injection Market Report

Report Metric	Details
Report Name	Omalizumab Injection Market
Accounted market size in 2025	US$ 5363 million
Forecasted market size in 2032	US$ 8108 million
CAGR	6.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Pre-Filled Subcutaneous Injection Solution Lyophilized Subcutaneous Injection Solution
Segment by Specifications	75mg 100mg 150mg
Segment by Purity	More than 99.0% 98.5%-99% 98.0%-98.5%
by Application	Allergic Asthma Chronic Spontaneous Urticaria (CSU)
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Celltrion, Reliance, Genentech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Specifications, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Omalizumab Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Omalizumab Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Omalizumab Injection Market growing?

Ans: The Omalizumab Injection Market witnessing a CAGR of 6.2% during the forecast period 2026-2032.

What is the Omalizumab Injection Market size in 2032?

Ans: The Omalizumab Injection Market size in 2032 will be US$ 8108 million.

Who are the main players in the Omalizumab Injection Market report?

Ans: The main players in the Omalizumab Injection Market are Novartis, Celltrion, Reliance, Genentech

What are the Application segmentation covered in the Omalizumab Injection Market report?

Ans: The Applications covered in the Omalizumab Injection Market report are Allergic Asthma, Chronic Spontaneous Urticaria (CSU)

What are the Type segmentation covered in the Omalizumab Injection Market report?

Ans: The Types covered in the Omalizumab Injection Market report are Pre-Filled Subcutaneous Injection Solution, Lyophilized Subcutaneous Injection Solution

1 Omalizumab Injection Market Overview

1.1 Product Definition

1.2 Omalizumab Injection by Type

1.2.1 Global Omalizumab Injection Market Value by Type: 2025 vs 2032

1.2.2 Pre-Filled Subcutaneous Injection Solution

1.2.3 Lyophilized Subcutaneous Injection Solution

1.3 Omalizumab Injection by Specifications

1.3.1 Global Omalizumab Injection Market Value by Specifications: 2025 vs 2032

1.3.2 75mg

1.3.3 100mg

1.3.4 150mg

1.4 Omalizumab Injection by Purity

1.4.1 Global Omalizumab Injection Market Value by Purity: 2025 vs 2032

1.4.2 More than 99.0%

1.4.3 98.5%-99%

1.4.4 98.0%-98.5%

1.5 Omalizumab Injection by Application

1.5.1 Global Omalizumab Injection Market Value by Application: 2025 vs 2032

1.5.2 Allergic Asthma

1.5.3 Chronic Spontaneous Urticaria (CSU)

1.6 Global Omalizumab Injection Market Size Estimates and Forecasts

1.6.1 Global Omalizumab Injection Revenue 2021–2032

1.6.2 Global Omalizumab Injection Sales 2021–2032

1.6.3 Global Omalizumab Injection Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Omalizumab Injection Market Competition by Manufacturers

2.1 Global Omalizumab Injection Sales Market Share by Manufacturers (2021–2026)

2.2 Global Omalizumab Injection Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Omalizumab Injection Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Omalizumab Injection, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Omalizumab Injection, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Omalizumab Injection, Product Types and Applications

2.7 Global Key Manufacturers of Omalizumab Injection, Date of Entry into the Industry

2.8 Global Omalizumab Injection Market Competitive Situation and Trends

2.8.1 Global Omalizumab Injection Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Omalizumab Injection Players Market Share by Revenue

2.8.3 Global Omalizumab Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Omalizumab Injection Market Scenario by Region

3.1 Global Omalizumab Injection Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Omalizumab Injection Sales by Region: 2021–2032

3.2.1 Global Omalizumab Injection Sales by Region: 2021–2026

3.2.2 Global Omalizumab Injection Sales by Region: 2027–2032

3.3 Global Omalizumab Injection Revenue by Region: 2021–2032

3.3.1 Global Omalizumab Injection Revenue by Region: 2021–2026

3.3.2 Global Omalizumab Injection Revenue by Region: 2027–2032

3.4 North America Omalizumab Injection Market Facts & Figures by Country

3.4.1 North America Omalizumab Injection Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Omalizumab Injection Sales by Country (2021–2032)

3.4.3 North America Omalizumab Injection Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Omalizumab Injection Market Facts & Figures by Country

3.5.1 Europe Omalizumab Injection Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Omalizumab Injection Sales by Country (2021–2032)

3.5.3 Europe Omalizumab Injection Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Omalizumab Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Omalizumab Injection Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Omalizumab Injection Sales by Region (2021–2032)

3.6.3 Asia Pacific Omalizumab Injection Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Omalizumab Injection Market Facts & Figures by Country

3.7.1 Latin America Omalizumab Injection Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Omalizumab Injection Sales by Country (2021–2032)

3.7.3 Latin America Omalizumab Injection Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Omalizumab Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Omalizumab Injection Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Omalizumab Injection Sales by Country (2021–2032)

3.8.3 Middle East and Africa Omalizumab Injection Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Omalizumab Injection Sales by Type (2021–2032)

4.1.1 Global Omalizumab Injection Sales by Type (2021–2026)

4.1.2 Global Omalizumab Injection Sales by Type (2027–2032)

4.1.3 Global Omalizumab Injection Sales Market Share by Type (2021–2032)

4.2 Global Omalizumab Injection Revenue by Type (2021–2032)

4.2.1 Global Omalizumab Injection Revenue by Type (2021–2026)

4.2.2 Global Omalizumab Injection Revenue by Type (2027–2032)

4.2.3 Global Omalizumab Injection Revenue Market Share by Type (2021–2032)

4.3 Global Omalizumab Injection Price by Type (2021–2032)

5 Segment by Application

5.1 Global Omalizumab Injection Sales by Application (2021–2032)

5.1.1 Global Omalizumab Injection Sales by Application (2021–2026)

5.1.2 Global Omalizumab Injection Sales by Application (2027–2032)

5.1.3 Global Omalizumab Injection Sales Market Share by Application (2021–2032)

5.2 Global Omalizumab Injection Revenue by Application (2021–2032)

5.2.1 Global Omalizumab Injection Revenue by Application (2021–2026)

5.2.2 Global Omalizumab Injection Revenue by Application (2027–2032)

5.2.3 Global Omalizumab Injection Revenue Market Share by Application (2021–2032)

5.3 Global Omalizumab Injection Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Company Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Omalizumab Injection Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Novartis Omalizumab Injection Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Celltrion

6.2.1 Celltrion Company Information

6.2.2 Celltrion Description and Business Overview

6.2.3 Celltrion Omalizumab Injection Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Celltrion Omalizumab Injection Product Portfolio

6.2.5 Celltrion Recent Developments/Updates

6.3 Reliance

6.3.1 Reliance Company Information

6.3.2 Reliance Description and Business Overview

6.3.3 Reliance Omalizumab Injection Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Reliance Omalizumab Injection Product Portfolio

6.3.5 Reliance Recent Developments/Updates

6.4 Genentech

6.4.1 Genentech Company Information

6.4.2 Genentech Description and Business Overview

6.4.3 Genentech Omalizumab Injection Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Genentech Omalizumab Injection Product Portfolio

6.4.5 Genentech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Omalizumab Injection Industry Chain Analysis

7.2 Omalizumab Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Omalizumab Injection Production Mode & Process Analysis

7.4 Omalizumab Injection Sales and Marketing

7.4.1 Omalizumab Injection Sales Channels

7.4.2 Omalizumab Injection Distributors

7.5 Omalizumab Injection Customer Analysis

8 Omalizumab Injection Market Dynamics

8.1 Omalizumab Injection Industry Trends

8.2 Omalizumab Injection Market Drivers

8.3 Omalizumab Injection Market Challenges

8.4 Omalizumab Injection Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Reliance

Celltrion

Genentech Inc

List of Tables

Table 1. Global Omalizumab Injection Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Omalizumab Injection Market Value by Specifications (US$ Million), 2025 vs 2032

Table 3. Global Omalizumab Injection Market Value by Purity (US$ Million), 2025 vs 2032

Table 4. Global Omalizumab Injection Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Omalizumab Injection Market Competitive Situation by Manufacturers in 2025

Table 6. Global Omalizumab Injection Sales (Units) of Key Manufacturers (2021–2026)

Table 7. Global Omalizumab Injection Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Omalizumab Injection Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Omalizumab Injection Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Omalizumab Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Omalizumab Injection, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Omalizumab Injection, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Omalizumab Injection, Product Types and Applications

Table 14. Global Key Manufacturers of Omalizumab Injection, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Omalizumab Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Omalizumab Injection Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Omalizumab Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Omalizumab Injection Sales by Region (Units), 2021–2026

Table 20. Global Omalizumab Injection Sales Market Share by Region (2021–2026)

Table 21. Global Omalizumab Injection Sales by Region (Units), 2027–2032

Table 22. Global Omalizumab Injection Sales Market Share by Region (2027–2032)

Table 23. Global Omalizumab Injection Revenue by Region (US$ Million), 2021–2026

Table 24. Global Omalizumab Injection Revenue Market Share by Region (2021–2026)

Table 25. Global Omalizumab Injection Revenue by Region (US$ Million), 2027–2032

Table 26. Global Omalizumab Injection Revenue Market Share by Region (2027–2032)

Table 27. North America Omalizumab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Omalizumab Injection Sales by Country (Units), 2021–2026

Table 29. North America Omalizumab Injection Sales by Country (Units), 2027–2032

Table 30. North America Omalizumab Injection Revenue by Country (US$ Million), 2021–2026

Table 31. North America Omalizumab Injection Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Omalizumab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Omalizumab Injection Sales by Country (Units), 2021–2026

Table 34. Europe Omalizumab Injection Sales by Country (Units), 2027–2032

Table 35. Europe Omalizumab Injection Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Omalizumab Injection Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Omalizumab Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Omalizumab Injection Sales by Region (Units), 2021–2026

Table 39. Asia Pacific Omalizumab Injection Sales by Region (Units), 2027–2032

Table 40. Asia Pacific Omalizumab Injection Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Omalizumab Injection Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Omalizumab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Omalizumab Injection Sales by Country (Units), 2021–2026

Table 44. Latin America Omalizumab Injection Sales by Country (Units), 2027–2032

Table 45. Latin America Omalizumab Injection Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Omalizumab Injection Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Omalizumab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Omalizumab Injection Sales by Country (Units), 2021–2026

Table 49. Middle East and Africa Omalizumab Injection Sales by Country (Units), 2027–2032

Table 50. Middle East and Africa Omalizumab Injection Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Omalizumab Injection Revenue by Country (US$ Million), 2027–2032

Table 52. Global Omalizumab Injection Sales (Units) by Type (2021–2026)

Table 53. Global Omalizumab Injection Sales (Units) by Type (2027–2032)

Table 54. Global Omalizumab Injection Sales Market Share by Type (2021–2026)

Table 55. Global Omalizumab Injection Sales Market Share by Type (2027–2032)

Table 56. Global Omalizumab Injection Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Omalizumab Injection Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Omalizumab Injection Revenue Market Share by Type (2021–2026)

Table 59. Global Omalizumab Injection Revenue Market Share by Type (2027–2032)

Table 60. Global Omalizumab Injection Price (US$/Unit) by Type (2021–2026)

Table 61. Global Omalizumab Injection Price (US$/Unit) by Type (2027–2032)

Table 62. Global Omalizumab Injection Sales (Units) by Application (2021–2026)

Table 63. Global Omalizumab Injection Sales (Units) by Application (2027–2032)

Table 64. Global Omalizumab Injection Sales Market Share by Application (2021–2026)

Table 65. Global Omalizumab Injection Sales Market Share by Application (2027–2032)

Table 66. Global Omalizumab Injection Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Omalizumab Injection Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Omalizumab Injection Revenue Market Share by Application (2021–2026)

Table 69. Global Omalizumab Injection Revenue Market Share by Application (2027–2032)

Table 70. Global Omalizumab Injection Price (US$/Unit) by Application (2021–2026)

Table 71. Global Omalizumab Injection Price (US$/Unit) by Application (2027–2032)

Table 72. Novartis Company Information

Table 73. Novartis Description and Business Overview

Table 74. Novartis Omalizumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. Novartis Omalizumab Injection Product

Table 76. Novartis Recent Developments/Updates

Table 77. Celltrion Company Information

Table 78. Celltrion Description and Business Overview

Table 79. Celltrion Omalizumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Celltrion Omalizumab Injection Product

Table 81. Celltrion Recent Developments/Updates

Table 82. Reliance Company Information

Table 83. Reliance Description and Business Overview

Table 84. Reliance Omalizumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Reliance Omalizumab Injection Product

Table 86. Reliance Recent Developments/Updates

Table 87. Genentech Company Information

Table 88. Genentech Description and Business Overview

Table 89. Genentech Omalizumab Injection Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Genentech Omalizumab Injection Product

Table 91. Genentech Recent Developments/Updates

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Omalizumab Injection Distributors List

Table 95. Omalizumab Injection Customers List

Table 96. Omalizumab Injection Market Trends

Table 97. Omalizumab Injection Market Drivers

Table 98. Omalizumab Injection Market Challenges

Table 99. Omalizumab Injection Market Restraints

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Product Picture of Omalizumab Injection

Figure 2. Global Omalizumab Injection Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Omalizumab Injection Market Share by Type: 2025 & 2032

Figure 4. Pre-Filled Subcutaneous Injection Solution Product Picture

Figure 5. Lyophilized Subcutaneous Injection Solution Product Picture

Figure 6. Global Omalizumab Injection Market Value by Specifications (US$ Million), 2021–2032

Figure 7. Global Omalizumab Injection Market Share by Specifications: 2025 vs 2032

Figure 8. 75mg Product Picture

Figure 9. 100mg Product Picture

Figure 10. 150mg Product Picture

Figure 11. Global Omalizumab Injection Market Value by Purity (US$ Million), 2021–2032

Figure 12. Global Omalizumab Injection Market Share by Purity: 2025 vs 2032

Figure 13. More than 99.0% Product Picture

Figure 14. 98.5%-99% Product Picture

Figure 15. 98.0%-98.5% Product Picture

Figure 16. Global Omalizumab Injection Market Value by Application (US$ Million), 2021–2032

Figure 17. Global Omalizumab Injection Market Share by Application: 2025 & 2032

Figure 18. Allergic Asthma

Figure 19. Chronic Spontaneous Urticaria (CSU)

Figure 20. Global Omalizumab Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Omalizumab Injection Market Size (US$ Million), 2021–2032

Figure 22. Global Omalizumab Injection Sales (Units), 2021–2032

Figure 23. Global Omalizumab Injection Average Price (US$/Unit), 2021–2032

Figure 24. Omalizumab Injection Report Years Considered

Figure 25. Omalizumab Injection Sales Share by Manufacturers in 2025

Figure 26. Global Omalizumab Injection Revenue Share by Manufacturers in 2025

Figure 27. Top 5 and Top 10 Global Omalizumab Injection Players: Market Share by Revenue in Omalizumab Injection in 2025

Figure 28. Omalizumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 29. Global Omalizumab Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 30. North America Omalizumab Injection Sales Market Share by Country (2021–2032)

Figure 31. North America Omalizumab Injection Revenue Market Share by Country (2021–2032)

Figure 32. United States Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Canada Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Europe Omalizumab Injection Sales Market Share by Country (2021–2032)

Figure 35. Europe Omalizumab Injection Revenue Market Share by Country (2021–2032)

Figure 36. Germany Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. France Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. U.K. Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Italy Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Russia Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Asia Pacific Omalizumab Injection Sales Market Share by Region (2021–2032)

Figure 42. Asia Pacific Omalizumab Injection Revenue Market Share by Region (2021–2032)

Figure 43. China Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Japan Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. South Korea Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. India Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Australia Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. China Taiwan Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Southeast Asia Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Latin America Omalizumab Injection Sales Market Share by Country (2021–2032)

Figure 51. Latin America Omalizumab Injection Revenue Market Share by Country (2021–2032)

Figure 52. Mexico Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Brazil Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Argentina Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Middle East and Africa Omalizumab Injection Sales Market Share by Country (2021–2032)

Figure 56. Middle East and Africa Omalizumab Injection Revenue Market Share by Country (2021–2032)

Figure 57. Turkey Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Saudi Arabia Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. UAE Omalizumab Injection Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Global Sales Market Share of Omalizumab Injection by Type (2021–2032)

Figure 61. Global Revenue Market Share of Omalizumab Injection by Type (2021–2032)

Figure 62. Global Omalizumab Injection Price (US$/Unit) by Type (2021–2032)

Figure 63. Global Sales Market Share of Omalizumab Injection by Application (2021–2032)

Figure 64. Global Revenue Market Share of Omalizumab Injection by Application (2021–2032)

Figure 65. Global Omalizumab Injection Price (US$/Unit) by Application (2021–2032)

Figure 66. Omalizumab Injection Value Chain

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions